The publisher's Medical Devices sector report, “Vascular Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Vascular Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Vascular grafts are tubes made up of natural tissue or synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vascular Grafts Overview
3 Products under Development
3.1 Vascular Grafts - Pipeline Products by Stage of Development
3.2 Vascular Grafts - Pipeline Products by Segment
3.3 Vascular Grafts - Pipeline Products by Territory
3.4 Vascular Grafts - Pipeline Products by Regulatory Path
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date
3.6 Vascular Grafts - Ongoing Clinical Trials
4 Vascular Grafts - Pipeline Products under Development by Companies
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development
4.2 Vascular Grafts - Pipeline Products by Stage of Development
5 Vascular Grafts Companies and Product Overview
6 Vascular Grafts- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
- Vascular Grafts - Pipeline Products by Stage of Development
- Vascular Grafts - Pipeline Products by Segment
- Vascular Grafts - Pipeline Products by Territory
- Vascular Grafts - Pipeline Products by Regulatory Path
- Vascular Grafts - Pipeline Products by Estimated Approval Date
- Vascular Grafts - Ongoing Clinical Trials
- Vascular Grafts Companies - Pipeline Products by Stage of Development
- Vascular Grafts - Pipeline Products by Stage of Development
- Glossary
- Vascular Grafts - Pipeline Products by Stage of Development
- Vascular Grafts - Pipeline Products by Segment
- Vascular Grafts - Pipeline Products by Territory
- Vascular Grafts - Pipeline Products by Regulatory Path
- Vascular Grafts - Pipeline Products by Estimated Approval Date
- Vascular Grafts - Ongoing Clinical Trials
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DT Holdings LLC
- Andes University
- Angiograft LLC
- Ariste Medical LLC
- Artivion Inc
- Aruga Technologies LLC
- BioDGraft GmbH
- BioIntegral Surgical Inc
- Biosurfaces Inc
- Cardiojustable LLC (Inactive)
- Cardiovate
- Colorado Therapeutics, LLC
- Cytograft Tissue Engineering Inc (Inactive)
- DSM Biomedical BV
- Eqalix, Inc.
- FIT Biotech Oy (Inactive)
- Gel-Del Technologies, Inc.
- Humacyte Inc
- Innovia LLC
- Merit Medical Systems Inc
- MicroPort Scientific Corp
- Nationwide Children's Hospital
- Northwestern University
- Peca Labs Inc
- PetVivo Holdings Inc
- PQ Bypass Inc
- RegenaGraft
- RUA Vascular Ltd
- Secant Group LLC
- Shanghai MicroPort Endovascular MedTech Co Ltd
- Southern University of Science and Technology
- Stanford University
- STENTiT
- Tgen Tech LLC
- Transmural systems LLC
- TTK Healthcare Ltd
- University of Louisville
- University of Pittsburgh
- Vascudyne Inc
- VenoStent Inc
- VesselTek BioMedical LLC
- VESSL Therapeutics Ltd
- Xeltis AG
